Development of a Practical, Minimally Invasive Seizure Gauge
NCT ID: NCT03745118
Last Updated: 2023-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
95 participants
INTERVENTIONAL
2018-11-19
2022-08-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of a Minimally Invasive Seizure Gauge
NCT03882671
Wearable Devices to Monitor Seizures in Autoimmune Epilepsy
NCT05627661
Seizure Detection and Warning System for Epilepsy Patients
NCT01874600
Sensor-Dot and Plug 'n Patch Study in Epilepsy
NCT04642105
Clinical Scenarios for Long-term Monitoring of Epileptic Seizures With a Wearable Biopotential Technology
NCT04284072
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the second year of the study patients who have implanted devices capable of recording or detecting seizures will be recruited to wear a noninvasive biosensor for multiple months. This data will be used to develop algorithms capable of detecting and/or forecasting seizures.
When the subjects clinical EEG monitoring is completed data scientists will analyze the data to identify patterns.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Monitoring Device
Subjects will be asked to wear up to 4 different noninvasive seizure detection devices including EpiTel EpiLog, Byte Flies Sensor Dots, Empatica E4, Biovotion Everion, GeneActiv
EpiTel EpiLog
Plastic pad that is about the size of a house key, and will be adhered to your scalp with gel
Byte Flies Sensor Dots
Plastic pads that will be adhered to your chest area
Empatica E4
wearable seizure detection wristband
Biovotion Everion
wearable seizure detection device armband that is attached to upper arm
GeneActiv
wearable seizure detection watch
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EpiTel EpiLog
Plastic pad that is about the size of a house key, and will be adhered to your scalp with gel
Byte Flies Sensor Dots
Plastic pads that will be adhered to your chest area
Empatica E4
wearable seizure detection wristband
Biovotion Everion
wearable seizure detection device armband that is attached to upper arm
GeneActiv
wearable seizure detection watch
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pediatric subjects 7 years of age or older.
Exclusion Criteria
* Presence of open or healing wounds near monitoring sites (infection risk).
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benjamin H. Brinkmann
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin (Ben) H. Brinkmann, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-008357
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.